Pazopanib/DCE-MRIs in Renal Cell Carcinoma (RCC)

Clinical trial NCT01221506 · COMPLETED

Trial details

NCT number: NCT01221506
Sponsor: Abramson Cancer Center at Penn Medicine
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2010-10-01
Primary completion: 2015-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.